OTC · Financial Statements
GeneThera, Inc. (GTHR) Financial Statements
$0.00
OTC: GTHR
Market Cap $3533
Overview Financials Dividend GeneThera, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 $0 $0 $0 $0 Operating Profit $-1.0M $-4.0M $-1.0M $-1.0M $-1.0M Net Profit $-1.0M $-4.0M $-1.0M $-1.0M $-1.0M EPS $-0.02 $-0.11 $-0.02 $-0.04 $-0.04 Op Margin — — — — —
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $0 $0 $0 $0 $0 Total Liabilities $7.0M $6.0M $7.0M $8.0M $8.0M Cash $0 $0 $0 $0 $0 Borrowings $1.0M $1.0M $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $0 $0 $0 $0 $0 Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $0 $0 $0 $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.81 FCF Yield -242.65% Quick Ratio 0.00 Interest Coverage -453.69 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock